ALBO
Albireo Pharma Inc
ALBO
ALBO
Delisted
ALBO was delisted on the 2nd of March, 2023.
34 hedge funds and large institutions have $5.58M invested in Albireo Pharma Inc in 2015 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 12 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
42% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 12
Holders
34
Holding in Top 10
–
Calls
$51K
Puts
$56K
Top Buyers
1 | +$364K | |
2 | +$113K | |
3 | +$84K | |
4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$51.4K |
5 |
SKK
Shepherd Kaplan Krochuk
Boston,
Massachusetts
|
+$44.1K |
Top Sellers
1 | -$1.66M | |
2 | -$1.3M | |
3 | -$279K | |
4 |
FMA
FNY Managed Accounts
New York
|
-$181K |
5 |
Goldman Sachs
New York
|
-$102K |